The Cooper Companies, Inc. (NYSE:COO) Shares Purchased by Neuberger Berman Group LLC

Neuberger Berman Group LLC lifted its position in The Cooper Companies, Inc. (NYSE:COOGet Rating) by 9.0% in the first quarter, Holdings Channel reports. The firm owned 182,514 shares of the medical device company’s stock after acquiring an additional 15,073 shares during the period. Neuberger Berman Group LLC’s holdings in Cooper Companies were worth $76,216,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp lifted its position in Cooper Companies by 24.2% during the 1st quarter. Bank of New York Mellon Corp now owns 1,089,699 shares of the medical device company’s stock worth $455,046,000 after acquiring an additional 212,257 shares during the period. JPMorgan Chase & Co. lifted its position in Cooper Companies by 17.4% during the 1st quarter. JPMorgan Chase & Co. now owns 1,120,044 shares of the medical device company’s stock worth $467,719,000 after acquiring an additional 165,647 shares during the period. BlackRock Inc. lifted its position in Cooper Companies by 4.1% during the 4th quarter. BlackRock Inc. now owns 4,000,869 shares of the medical device company’s stock worth $1,676,126,000 after acquiring an additional 158,358 shares during the period. Invesco Ltd. lifted its position in Cooper Companies by 10.8% during the 1st quarter. Invesco Ltd. now owns 1,620,188 shares of the medical device company’s stock worth $676,575,000 after acquiring an additional 157,305 shares during the period. Finally, Alliancebernstein L.P. raised its stake in shares of Cooper Companies by 67.2% during the 4th quarter. Alliancebernstein L.P. now owns 332,846 shares of the medical device company’s stock worth $139,443,000 after buying an additional 133,785 shares in the last quarter. 97.09% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Robert W. Baird cut their target price on Cooper Companies from $375.00 to $345.00 and set a “neutral” rating for the company in a research note on Thursday, September 1st. TheStreet downgraded Cooper Companies from a “b-” rating to a “c+” rating in a research note on Monday, July 18th. Stifel Nicolaus cut their target price on Cooper Companies from $475.00 to $450.00 in a research note on Monday, June 6th. Stephens cut their target price on Cooper Companies from $500.00 to $460.00 and set an “overweight” rating for the company in a research note on Friday, June 3rd. Finally, Citigroup cut their target price on Cooper Companies from $406.00 to $350.00 and set a “buy” rating for the company in a research note on Thursday, September 1st. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $406.00.

Cooper Companies Price Performance

Shares of NYSE:COO opened at $291.45 on Friday. The business’s fifty day moving average price is $311.91 and its two-hundred day moving average price is $345.74. The stock has a market cap of $14.38 billion, a PE ratio of 33.69, a price-to-earnings-growth ratio of 2.34 and a beta of 0.93. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.71 and a current ratio of 1.16. The Cooper Companies, Inc. has a one year low of $283.03 and a one year high of $444.22.

Cooper Companies (NYSE:COOGet Rating) last announced its earnings results on Wednesday, August 31st. The medical device company reported $3.19 EPS for the quarter, missing analysts’ consensus estimates of $3.24 by ($0.05). The company had revenue of $843.40 million for the quarter, compared to analyst estimates of $830.22 million. Cooper Companies had a net margin of 13.38% and a return on equity of 9.22%. Cooper Companies’s quarterly revenue was up 10.5% compared to the same quarter last year. During the same quarter last year, the company posted $3.41 EPS. On average, analysts forecast that The Cooper Companies, Inc. will post 12.79 EPS for the current fiscal year.

Cooper Companies Dividend Announcement

The business also recently announced a semi-annual dividend, which was paid on Thursday, August 11th. Shareholders of record on Wednesday, July 27th were issued a dividend of $0.03 per share. The ex-dividend date was Tuesday, July 26th. Cooper Companies’s dividend payout ratio (DPR) is presently 0.69%.

Cooper Companies Profile

(Get Rating)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NYSE:COOGet Rating).

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.